GI oncology Clinical Trials in Dallas, TX

As of August 2026, 57 paid clinical trials are recruiting for GI oncology in Dallas, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

57 clinical trials for GI oncology

·Clear filters·

Email me when a new gi oncology trial opens in Dallas, TX.

CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules

for HCC

Sites in Dallas +1 more location

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT06184152·Recruiting·Listed Dec 2023

Apply to this trial

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

for Esophageal Cancer

1 location in Dallas

Sponsor: John Waters

Sex: All·Age: 18+

Code: NCT07039526·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

Ligufalimab and Cadonilimab in Advanced Liver Cancers

for Advanced Hepatocellular Carcinoma

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT06789848·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

for Barretts Esophagus With Dysplasia

Sites in Dallas, Houston +21 more locations

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 89

Code: NCT05753748·Recruiting·Listed Mar 2023

Apply to this trial

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

for Esophageal Adenocarcinoma

Sites in Dallas, Houston +5 more locations

Sponsor: VA Office of Research and Development

Sex: All·Age: 18+

Code: NCT05563766·Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

for Pancreatic Cancer

Sites in Dallas +10 more locations

Sponsor: University of Louisville

Sex: All·Age: 18+

Code: NCT02674100·Recruiting·Listed Feb 2016

Apply to this trial

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

for Ovarian Cancer

Sites in Dallas +1 more location

Sponsor: Hefei TG ImmunoPharma Co., Ltd.

Sex: All·Age: 18+

Code: NCT05746897·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

for Pancreatic Adenocarcinoma

1 location in Dallas

Sponsor: Baylor Research Institute

Sex: All·Age: 18+

Code: NCT04926467·Phase 2·Recruiting·Listed Jun 2021

Apply to this trial

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

for Esophagus Adenocarcinoma

1 location in Dallas

Sponsor: Dallas VA Medical Center

Sex: All·Age: 18+

Code: NCT04018872·Phase 2·Recruiting·Listed Jul 2019

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

Sites in Dallas, Sherman +70 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

for HNSCC

Sites in Dallas, Houston +16 more locations

Sponsor: Normunity AccelCo, Inc.

Sex: All·Age: 18+

Code: NCT07182149·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

DESTINY-PANTUMOUR04

for Adenocarcinoma (NOS)

Sites in Dallas +17 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT07124000·Recruiting·Listed Aug 2025

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

Sites in Dallas, Houston +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for Biliary Tract Cancer

Drug: Rilvegostomig

Sites in Dallas, Fort Worth +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 99

Code: NCT06467357·Phase 3·Recruiting·Listed Jun 2024

Apply to this trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for HER2-positive Gastric Cancer

Drug: Rilvegostomig

Sites in Dallas, Round Rock +43 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for Triple Negative Breast Cancer

Sites in Dallas, Austin +8 more locations

Sponsor: Dren Bio

Sex: All·Age: 18+

Code: NCT06999187·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

for Hepatocellular Carcinoma

1 location in Dallas

Sponsor: Can-Fite BioPharma

Sex: All·Age: 18+

Code: NCT05201404·Phase 3·Recruiting·Listed Jan 2022

Apply to this trial

Conditions in GI oncology (Dallas, TX)

Pancreatic cancer· 20 Colorectal cancer· 19 Gastric cancer· 16 Esophageal cancer· 11 Liver cancer· 8 Gastroesophageal junction cancer· 7 Biliary tract cancer· 5 Metastatic colorectal cancer· 2